Literature DB >> 14991124

[Erectile dysfunction. Epidemiology, physiology, etiology, diagnosis and therapy].

H Derouet1, J Osterhage, H Sittinger.   

Abstract

Erectile dysfunction is a common, age-dependent functional disturbance of men associated to various comorbidities. Interdisciplinary cooperation with neurologists in cases of a suspected neurological aetiology and with psychiatrists in cases with normal organic diagnostic findings is necessary. Hormone replacement and psychotherapy can cure certain patients. Oral pharmacotherapy is the most effective therapy for erectile dysfunction with the highest patient preference. Oral PDE-5-inhibitors (sildenafil, tadalafil, vardenafil) are superior in effectiveness to centrally acting drugs (apomorphin, yohimbine). Local pharmacotherapy (MUSE, ICI) is a second line therapy in cases of failure or contraindications for oral pharmacotherapy. Vacuum therapy and operative procedures (penile implants) complete the therapeutic options of erectile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991124     DOI: 10.1007/s00120-003-0527-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  30 in total

1.  Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research.

Authors:  E F Lizza; R C Rosen
Journal:  Int J Impot Res       Date:  1999-06       Impact factor: 2.896

2.  Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue.

Authors:  C G Stief; S Uckert; A J Becker; W Harringer; M C Truss; W G Forssmann; U Jonas
Journal:  Urology       Date:  2000-01       Impact factor: 2.649

Review 3.  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors: 
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

4.  Haemodynamics of erection in man.

Authors:  V Michal; J Simána; J Rehák; J Masín
Journal:  Physiol Bohemoslov       Date:  1983

Review 5.  Psychological subtypes of erectile dysfunction: results of statistically analyses and clinical practice.

Authors:  U Hartmann
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients.

Authors:  F Montorsi; P Rigatti; G Carmignani; C Corbu; B Campo; G Ordesi; G Breda; P Silvestre; B Giammusso; G Morgia; A Graziottin
Journal:  Eur Urol       Date:  2000-01       Impact factor: 20.096

Review 7.  Approaches for the development of oral drug therapies for erectile dysfunction.

Authors:  M M Foreman; J F Wernicke
Journal:  Semin Urol       Date:  1990-05

8.  Apomorphine: an update of clinical trial results.

Authors:  J P Heaton
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

9.  The use of conventional electromyography to assess external sphincter neuropathy in man.

Authors:  D C Bartolo; J A Jarratt; N W Read
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

10.  Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.

Authors:  Gerald B Brock; Chris G McMahon; K K Chen; Timothy Costigan; Wei Shen; Vish Watkins; Greg Anglin; Steve Whitaker
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  1 in total

1.  [Quality assurance in the urologist's practice. Erectile dysfunction as an example of a multicenter approach to documenting treatment results].

Authors:  K-P Jünemann; S Cassens; H Lippert; M Burkart
Journal:  Urologe A       Date:  2005-07       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.